Optimal First-Line Medico-Surgical Strategy in Ovarian Cancers: Are We There Yet?

por Quesada, Stanislas, Thomas, Quentin Dominique, Colombo, Pierre-Emmanuel, Fiteni, Frederic
Publicado 2023

Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction

por Colombo, Pierre-Emmanuel, Milanezi, Fernanda, Weigelt, Britta, Reis-Filho, Jorge S
Publicado 2011

Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

por Corbeau, Ileana, Thezenas, Simon, Maran-Gonzalez, Aurelie, Colombo, Pierre-Emmanuel, Jacot, William, Guiu, Severine
Publicado 2020

Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid Cancers

por Chabab, Ghita, Boissière-Michot, Florence, Mollevi, Caroline, Ramos, Jeanne, Lopez-Crapez, Evelyne, Colombo, Pierre-Emmanuel, Jacot, William, Bonnefoy, Nathalie, Lafont, Virginie
Publicado 2020

High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers

por Jacot, William, Mollevi, Caroline, Fina, Frédéric, Lopez-Crapez, Evelyne, Martin, Pierre-Marie, Colombo, Pierre-Emmanuel, Bibeau, Frédéric, Romieu, Gilles, Lamy, Pierre-Jean
Publicado 2015

Assessing Histology Structures by Ex Vivo MR Microscopy and Exploring the Link Between MRM-Derived Radiomic Features and Histopathology in Ovarian Cancer

por Tardieu, Marion, Lakhman, Yulia, Khellaf, Lakhdar, Cardoso, Maida, Sgarbura, Olivia, Colombo, Pierre-Emmanuel, Crispin-Ortuzar, Mireia, Sala, Evis, Goze-Bac, Christophe, Nougaret, Stephanie
Publicado 2022

Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse

por du Manoir, Stanislas, Orsetti, Béatrice, Bras-Gonçalves, Rui, Nguyen, Tien-Tuan, Lasorsa, Laurence, Boissière, Florence, Massemin, Blandine, Colombo, Pierre-Emmanuel, Bibeau, Frédéric, Jacot, William, Theillet, Charles
Publicado 2013

Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospectiv...

por Taoum, Christophe, Carrier, Guillaume, Jarlier, Marta, Roche, Gwenaelle, Gagniere, Johan, Fiess, Catherine, De forges, Helene, Chevarin, Caroline, Colombo, Pierre-Emmanuel, Barnich, Nicolas, Rouanet, Philippe, Bonnet, Mathilde
Publicado 2022

Differential Sensitivity of Germline and Somatic BRCA Variants to PARP Inhibitor in High-Grade Serous Ovarian Cancer

por Vendrell, Julie A., Ban, Iulian O., Solassol, Isabelle, Audran, Patricia, Cabello-Aguilar, Simon, Topart, Delphine, Lindet-Bourgeois, Clothilde, Colombo, Pierre-Emmanuel, Legouffe, Eric, D’Hondt, Véronique, Fabbro, Michel, Solassol, Jérôme
Publicado 2023

BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib

por Velazquez, Carolina, Orhan, Esin, Tabet, Imene, Fenou, Lise, Orsetti, Béatrice, Adélaïde, José, Guille, Arnaud, Thézénas, Simon, Crapez, Evelyne, Colombo, Pierre-Emmanuel, Chaffanet, Max, Birnbaum, Daniel, Sardet, Claude, Jacot, William, Theillet, Charles
Publicado 2023

Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure

por Colombo, Pierre-Emmanuel, du Manoir, Stanislas, Orsetti, Béatrice, Bras-Gonçalves, Rui, Lambros, Mario B., MacKay, Alan, Nguyen, Tien-Tuan, Boissiére, Florence, Pourquier, Didier, Bibeau, Frédéric, Reis-Filho, Jorge S., Theillet, Charles
Publicado 2015

Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells

por Chauvin, Maëva, Garambois, Véronique, Colombo, Pierre-Emmanuel, Chentouf, Myriam, Gros, Laurent, Brouillet, Jean-Paul, Robert, Bruno, Jarlier, Marta, Dumas, Karen, Martineau, Pierre, Navarro-Teulon, Isabelle, Pépin, David, Chardès, Thierry, Pèlegrin, André
Publicado 2021

Negative Survival Impact of Occult Lymph Node Involvement in Small HER2-Positive Early Breast Cancer Treated by Up-Front Surgery

por Houvenaeghel, Gilles, Cohen, Monique, Martino, Marc, Reyal, Fabien, Classe, Jean-Marc, Chauvet, Marie-Pierre, Colombo, Pierre-Emmanuel, Heinemann, Mellie, Jouve, Eva, Gimbergues, Pierre, Azuar, Anne-Sophie, Coutant, Charles, Gonçalves, Anthony, de Nonneville, Alexandre
Publicado 2023

Conditional Probability of Survival and Prognostic Factors in Long-Term Survivors of High-Grade Serous Ovarian Cancer

por Fabbro, Michel, Colombo, Pierre-Emmanuel, Leaha, Cristina Marinella, Rouanet, Philippe, Carrère, Sébastien, Quenet, François, Gutowski, Marian, Mourregot, Anne, D’Hondt, Véronique, Coupier, Isabelle, Vendrell, Julie, Vilquin, Paul, Pujol, Pascal, Solassol, Jérôme, Mollevi, Caroline
Publicado 2020

Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy

por Neron, Mathias, Guille, Arnaud, Allegre, Lucie, Colombo, Pierre-Emmanuel, Leaha, Cristina, Adelaide, José, Carbuccia, Nadine, Courtier, Frédéric, Boissiere, Florence, Crapez, Evelyne, Fabbro, Michel, Gouy, Sébastien, Mamessier, Emilie, Lambaudie, Éric, Birnbaum, Daniel, Bertucci, François, Chaffanet, Max
Publicado 2022

Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival

por Chauvin, Maëva, Garambois, Véronique, Choblet, Sylvie, Colombo, Pierre-Emmanuel, Chentouf, Myriam, Gros, Laurent, De Brauwere, David-Paul, Duonor-Cerutti, Martine, Dumas, Karen, Robert, Bruno, Jarlier, Marta, Martineau, Pierre, Navarro-Teulon, Isabelle, Pépin, David, Chardès, Thierry, Pèlegrin, André
Publicado 2021

Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study

por Alejandra, Martinez, Gertych, Witold, Pomel, Christophe, Ferron, Gwenael, Lusque, Amelie, Angeles, Martina Aida, Lambaudie, Eric, Rouzier, Roman, Bakrin, Naoual, Golfier, Francois, Glehen, Olivier, Canis, Michel, Bourdel, Nicolas, Pouget, Nicolas, Colombo, Pierre-Emmanuel, Guyon, Frédéric, Meurette, Jacques, Querleu, Denis
Publicado 2021

Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models

por Rabia, Emilia, Garambois, Véronique, Hubert, Julie, Bruciamacchie, Marine, Pirot, Nelly, Delpech, Hélène, Broyon, Morgane, Theillet, Charles, Colombo, Pierre-Emmanuel, Vie, Nadia, Tosi, Diego, Gongora, Celine, Khellaf, Lakhdar, Jarlier, Marta, Radosevic-Robin, Nina, Chardès, Thierry, Pèlegrin, André, Larbouret, Christel
Publicado 2021

The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway

por Laprevotte, Emilie, Cochaud, Stéphanie, du Manoir, Stanislas, Lapierre, Marion, Dejou, Cécile, Philippe, Marion, Giustiniani, Jérome, Frewer, Kathryn A., Sanders, Andrew J., Jiang, Wen G., Michaud, Henri-Alexandre, Colombo, Pierre-Emmanuel, Bensussan, Armand, Alberici, Gilles, Bastid, Jérémy, Eliaou, Jean-François, Bonnefoy, Nathalie
Publicado 2017

Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study

por Michalet, Morgan, Bordeau, Karl, Cantaloube, Marie, Valdenaire, Simon, Debuire, Pierre, Simeon, Sebastien, Portales, Fabienne, Draghici, Roxana, Ychou, Marc, Assenat, Eric, Dupuy, Marie, Gourgou, Sophie, Colombo, Pierre-Emmanuel, Carrere, Sebastien, Souche, François-Regis, Aillères, Norbert, Fenoglietto, Pascal, Azria, David, Riou, Olivier
Publicado 2022